These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17207314)

  • 21. Approaches to improving recruitment and retention of minority elders participating in research: examples from selected research groups including the National Institute on Aging's Resource Centers for Minority Aging Research.
    Stahl SM; Vasquez L
    J Aging Health; 2004 Nov; 16(5 Suppl):9S-17S. PubMed ID: 15448284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
    Joseph G; Dohan D
    Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research.
    Seto B
    Am J Med Sci; 2001 Nov; 322(5):248-50. PubMed ID: 11721795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minority report.
    Wallis L
    Nurs Stand; 2003 Jan 29-Feb 4; 17(20):16-7. PubMed ID: 12629879
    [No Abstract]   [Full Text] [Related]  

  • 25. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research.
    Seto B
    Am J Med Sci; 2001 Nov; 322(5):248-52. PubMed ID: 11876183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Prevention Program meets recruitment goals.
    Klonoff DC
    Diabetes Technol Ther; 1999; 1(3):350-1. PubMed ID: 11475280
    [No Abstract]   [Full Text] [Related]  

  • 27. Recruitment and retention strategies in clinical studies with low-income and minority populations: Progress from 2004-2014.
    Nicholson LM; Schwirian PM; Groner JA
    Contemp Clin Trials; 2015 Nov; 45(Pt A):34-40. PubMed ID: 26188163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recruiting minorities into clinical trials: toward a participant-friendly system.
    Swanson GM; Ward AJ
    J Natl Cancer Inst; 1995 Dec; 87(23):1747-59. PubMed ID: 7473831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Participant recruitment from minority religious groups: the case of the Islamic population in South Australia.
    Mohammadi N; Jones T; Evans D
    Int Nurs Rev; 2008 Dec; 55(4):393-8. PubMed ID: 19146549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials-an NRG Oncology RTOG Study.
    Wells JS; Pugh S; Boparai K; Rearden J; Yeager KA; Bruner DW
    J Cancer Educ; 2017 Dec; 32(4):721-727. PubMed ID: 27209044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minority enrollment on clinical trials enhances scientific rigor but requires structural changes and commitment.
    Doll KM
    Gynecol Oncol; 2020 May; 157(2):301-302. PubMed ID: 32389197
    [No Abstract]   [Full Text] [Related]  

  • 32. Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards.
    Picillo M; Kou N; Barone P; Fasano A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1041-8. PubMed ID: 26228079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach.
    Bolen S; Tilburt J; Baffi C; Gary TL; Powe N; Howerton M; Ford J; Lai G; Wilson R; Bass E
    Cancer; 2006 Mar; 106(6):1197-204. PubMed ID: 16453333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic minority under-representation in clinical trials. Whose responsibility is it anyway?
    Hussain-Gambles M
    J Health Organ Manag; 2003; 17(2):138-43. PubMed ID: 12916177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underrepresentation of minorities in clinical trials: a current problem with escalating future implications.
    Galvao M
    Heart Lung; 2011; 40(5):391-2. PubMed ID: 21784528
    [No Abstract]   [Full Text] [Related]  

  • 36. Disparities in participation in cancer clinical trials.
    Bjarnason NH
    JAMA; 2004 Aug; 292(8):922; author reply 922-3. PubMed ID: 15328321
    [No Abstract]   [Full Text] [Related]  

  • 37. Strategies for recruiting and retaining minorities.
    DeBaun MR; Gorelick PB; Som S
    Front Neurol Neurosci; 2009; 25():118-120. PubMed ID: 19478507
    [No Abstract]   [Full Text] [Related]  

  • 38. Web applications aid clinical trial recruitment.
    Cancer Discov; 2012 Feb; 2(2):OF2. PubMed ID: 22585864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing participation of minorities in cancer clinical trials: summary of the "Moving Beyond the Barriers" Conference in North Carolina.
    Stark N; Paskett E; Bell R; Cooper MR; Walker E; Wilson A; Tatum C
    J Natl Med Assoc; 2002 Jan; 94(1):31-9. PubMed ID: 11837350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exclusions from clinical trials in Australia based on proficiency in English.
    Stanaway F; Cumming RG; Blyth F
    Med J Aust; 2017 Jul; 207(1):36. PubMed ID: 28659113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.